The CRISPR-led gene-editing revolution is set to begin next month in its first ever trial in humans. The small phase 1 trial, to take place in China, will be investigating the method’s safety ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin.

以色列特拉维夫大学研究人员在一项创新研究中，使用“基因魔剪”CRISPR技术，从头颈部肿瘤的癌细胞中成功切除了特定基因，并在模式动物实验中消除了50%的肿瘤。这一研究成果发表于最新一期《先进科学》杂志。

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

Versions of the species carrying Zika and dengue fever can be manipulated with CRISPR so that they give birth to sterile offspring, below. David Liittschwager Mosquito larvae in the laboratory of ...

ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and development of gene editing ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP stock is mainly due to a lack of pipeline updates, which is not sitting ...

CRISPR Therapeutics' stock is down 19% since December, with a slow Casgevy launch and significant R&D investments, yet strong cash reserves provide a safety net. Q4 earnings show no revenue from ...